PHRT Trademark

Trademark Overview

On Saturday, April 22, 2023, a trademark application was filed for PHRT with the United States Patent and Trademark Office. The USPTO has given the PHRT trademark a serial number of 97902152. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Friday, December 6, 2024. This trademark is owned by Women's Hormone Network Inc. The PHRT trademark is filed in the Pharmaceutical Products category with the following description:

Hormone replacement therapy preparations; Hormones; Hormones for medical purposes

General Information

Serial Number97902152
Word MarkPHRT
Filing DateSaturday, April 22, 2023
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateFriday, December 6, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesHormone replacement therapy preparations; Hormones; Hormones for medical purposes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 19, 2023
Primary Code005
First Use Anywhere DateMonday, January 9, 2023
First Use In Commerce DateWednesday, April 24, 2024

Trademark Owner History

Party NameWomen's Hormone Network Inc
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSanta Barbara, CA 93108

Trademark Events

Event DateEvent Description
Wednesday, April 26, 2023NEW APPLICATION ENTERED
Friday, May 19, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, January 19, 2024ASSIGNED TO EXAMINER
Monday, January 22, 2024NON-FINAL ACTION WRITTEN
Monday, January 22, 2024NON-FINAL ACTION E-MAILED
Monday, January 22, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, April 18, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 18, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 18, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 23, 2024FINAL REFUSAL WRITTEN
Thursday, May 23, 2024FINAL REFUSAL E-MAILED
Thursday, May 23, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, July 16, 2024TEAS AMENDMENT OF USE RECEIVED
Tuesday, July 16, 2024AMENDMENT TO USE PROCESSING COMPLETE
Tuesday, July 16, 2024USE AMENDMENT FILED
Wednesday, August 14, 2024REPORT UNRESPONSIVE AMENDMENT - COMPLETED
Wednesday, August 14, 2024USE AMENDMENT ACCEPTED
Wednesday, August 14, 2024NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED
Wednesday, August 14, 2024NOTIFICATION OF NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED
Friday, August 23, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 23, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 23, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, October 3, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, October 3, 2024NON-FINAL ACTION WRITTEN
Thursday, October 3, 2024NON-FINAL ACTION E-MAILED
Thursday, December 5, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 5, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, December 6, 2024TEAS/EMAIL CORRESPONDENCE ENTERED

Related Keywords

phrt hormones medical purposes preparations replacement therapy hormone